Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025

03.06.25 12:57 Uhr

Werte in diesem Artikel
Aktien

83,48 EUR -2,82 EUR -3,27%

The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)
Ellehammersvej 20, 2770 Kastrup
from 10.30 - 17.00 CEST
(Central European Summer Time)

Wer­bung

Coloplast invites institutional investors, equity analysts and media to attend our 2025 Capital Markets Day.
The event will be held in person at Clarion Hotel in Copenhagen, Denmark, with the option to join virtually for the plenary session.
The purpose of the event is to give institutional investors and financial analysts an introduction to the new 5-year strategy for the company, as well as to provide the opportunity to meet with the broader Management team.
The day will start with a plenary session, covering the introduction of the new Group strategy, a financial update, and the strategy for the Chronic Care businesses. In the afternoon, participants will be split into groups and rotate between four Q&A breakout sessions. Participation in the breakout sessions will be in-person only (with a replay of the presentations available after the event).
The formal program will end at 17.00, followed by an opportunity to meet the Coloplast management team in an informal setting.

Agenda in CEST
10.00 - 10.30  Registration
10.30 - 12.30  Plenary session: Group strategy and financials, strategy for Chronic Care and Voice and Respiratory Care
12.30 - 13.00  Lunch break
13.00 - 17.00  Q&A breakout sessions (incl. breaks)
17.00 - 18.30  Social activity (on premise)

Coloplast representatives

Plenary session:  
  Lars Rasmussen, Interim President and CEO
  Anders Lonning-Skovgaard, Executive Vice President, CFO
  Nicolai Buhl, Executive Vice President, Chronic Care
  Caroline Vagner Rosenstand, Executive Vice President, Voice & Respiratory Care

Wer­bung

Breakout sessions:  
  Chronic Care deep dive:
  Mike DelVacchio, Senior Vice President, North America
  Thomas Bruhn, Senior Vice President, Emerging Markets

  Advanced Wound Care:
  Fertram Sigurjonsson, Founder and President, Kerecis
  Bernd Greiner, Senior Vice President, Adv. Wound Dressings

  Interventional Urology:
  Thomas NP Johns Jr, Executive Vice President, Interventional Urology

Wer­bung

  Global Operations and People & Culture:
  Allan Rasmussen, Executive Vice President, Global Operations
  Dorthe Rønnau, Executive Vice President, People & Culture

In-person participation
If you wish to join us in-person and attend the plenary session and the Q&A breakout sessions, please register by sending an email to CMD2025@coloplast.com stating your full name, company, contact phone number and itinerary (if relevant).
Kindly register before Friday, 15 August 2025.

Virtual participation
Virtual participation will be possible for the plenary session.
A link for the webcast of the plenary sessions will be available on our website closer to the date.

For more information,
please contact:

Aleksandra Dimovska, Vice President
Direct tel.: +45 4911 2458
E-mail: dkadim@coloplast.com 

Simone Dyrby Helvind, Sr. Manager  
Direct tel.: +45 4911 2981
E-mail: dksdk@coloplast.com 

Julie Sommer Müggler, Coordinator   
Direct tel.: +45 4911 3161
Email: dkjusm@coloplast.com 

Attachment


Ausgewählte Hebelprodukte auf Coloplast A-S (B)

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Coloplast A-S (B)

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Coloplast A-S (B)

Wer­bung

Analysen zu Coloplast A-S (B)

DatumRatingAnalyst
04.12.2012Coloplast equal-weightMorgan Stanley
04.07.2012Coloplast neutralJ.P. Morgan Cazenove
15.03.2012Coloplast sellUBS AG
07.12.2011Coloplast buySociété Générale Group S.A. (SG)
DatumRatingAnalyst
07.12.2011Coloplast buySociété Générale Group S.A. (SG)
DatumRatingAnalyst
04.12.2012Coloplast equal-weightMorgan Stanley
04.07.2012Coloplast neutralJ.P. Morgan Cazenove
DatumRatingAnalyst
15.03.2012Coloplast sellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Coloplast A-S (B) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen